Fampride (which is supposedly somewhat similar to Amifampridine but not quite the same) had a large Phase 2 trial for Long-Covid aimed at...
I can see this being sensible if applied well, but am I wrong or doesn't the whole concept depend on what kind of patients you're recruiting and...
So possibly a complex disordered expression of certain genes, for which the likelihood of an overexpression in certain cells taking place somehow...
The narrative behind this trial is probably some vague idea in relation to ATP, similar to what is being proposed by the author here: Metabolic...
TRI-ME: Trimetazidine to treat Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A double-blind, randomised, placebo-controlled efficacy trial...
I doubt it. The astronauts all go back to "normal" after having experienced certain circumstances. The BPS theory is not that ME/CFS-like...
Apart from the thing mentioned by Yann above, I think there have been a few looking at connections. Rob Wüst has done research together with ESA...
If the plot was correct then figure 1B wouldn't be correct, so I would suspect that it indeed might be the plot.
If @forestglip feels up to it he might re-run the analysis. The fact that they mention a p-value in the abstract but don't mention the high...
I believe there must have been dozens of studies looking at EBV in saliva (they did so themselvels as well:...
Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults with Post-COVID-19 Condition (PCC) (THALASSA) Brief Summary The study aims to...
As far as I've heard that wouldn't be possible because this is just an observational cohort (so people aren't getting diagnosed with things such...
"people with other subsets (autoantibodies, MCAS, etc.)" doesn't inspire too much confidence in the article for me.
Yes and I would image you will have had to have seen thousands of "easy cases" to know what a complex case looks like. But I can imagine quite...
No. Everyone met the IOM criteria. Not everyone met the CCC criteria (largerly because of a lack of pain rather than anything else).
That is also my understanding and the reason why as ME/CFS Skeptic blog details so well, a good reason to think that POTS may not be the nature of...
As far as I've seen, I don't think this is the case. Most people that applied for the study didn't get in because they failed had been ill for...
This article is by Martin Rücker. Martin Rücker has for the past years had a focus on topics surrounding ME/CFS and Long-Covid (particularly...
Has somebody done a crosscomparison between CBT/GET and placebo in the Rituximab trials? My vague understanding is that those improvements...
Is that the case? I had the impression that there were also people reporting permanent recovery, which as I understand it wouldn't suit the...
Separate names with a comma.
